Skip to main content
SpringerLink
Log in

ASCO-Leitlinie für die Behandlung von NSCLC im Stadium III Teil 3: Indikationen zur neoadjuvanten Therapie

ASCO guideline for the management of stage III NSCLC part 3: indications for neoadjuvant therapy

  • Journal Club
  • Published:
Der Chirurg Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Herz- und Thoraxchirurgie, Universität zu Köln, Kerpener Str. 62, 50931, Köln, Deutschland

    Khosro Hekmat

  2. Klinik und Poliklinik Allgemein‑, Viszeral- und Tumorchirurgie, Universität zu Köln, Kerpener Str. 62, 50931, Köln, Deutschland

    Christiane J. Bruns

Authors
  1. Khosro Hekmat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christiane J. Bruns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Khosro Hekmat.

Ethics declarations

Interessenkonflikt

K. Hekmat und C.J. Bruns geben an, dass kein Interessenkonflikt besteht.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hekmat, K., Bruns, C.J. ASCO-Leitlinie für die Behandlung von NSCLC im Stadium III Teil 3: Indikationen zur neoadjuvanten Therapie. Chirurg 93, 403–404 (2022). https://doi.org/10.1007/s00104-022-01602-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-022-01602-1

Search

Navigation